Blow fill Seal Horizon Pharmaceuticals packaging BFS aseptic steril bottles

Posted On Sep 16 2016 by

#horizon pharma # Horizon Pharmaceuticals, Inc. Horizon Pharmaceuticals, Inc. is a company focused on the development, manufacture and life cycle management of Blow-Fill-Seal (BFS) tech no logy and products for the pharmaceutical, medical device, diagnostic and clinical industries. Horizon is an independent pharmaceutical company uniquely positioned in the industry to fulfill Blow-Fill-Seal product development needs. Horizon has the capabilities to complete projects from any stage of the development cycle. Horizon operates two segments, Blow-Fill-Seal drug discovery and development, and Blow-Fill-Seal manufacturing, including in-house mold fabrication. Horizon Pharmaceutical, Inc. Aseptic BFS Pharmaceutical Manufacturing Palm Beach County, FL For Business development please …


HZNP Stock Price & News – Horizon Pharma PLC – Wall Street Journal

Posted On Sep 16 2016 by

#horizon pharma # Horizon Pharma PLC HZNP (U.S. Nasdaq) P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock’s most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period. Earnings Per Share (TTM) A company’s net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock’s price. For …


Dusa Pharma: Latest News – Videos, Photos about Dusa Pharma

Posted On Sep 16 2016 by

#dusa pharma # DUSA PHARMA Pharma headwinds here to stay, tread with caution Seven pharma cos’ managements say pricing pressure and tightening regulatory noose worrisome in near term, but long-term outlook’s healthy. 1 Sep, 2016, 08.22AM IST IT, pharma ultimately going to perform: Rakesh Jhunjhunwala In IT and pharma, the first few names remain the same, but the order keeps changi. 30 Aug, 2016, 12.25PM IST Pharma companies in race to acquire Zincovit, Zincofer Leading pharma players Cadila Healthcare, Torrent Pharma and GSK Pharma are in a three. 29 Aug, 2016, 05.13PM IST Buy Escorts and Sun Pharma: Experts As …


SPI Pharma

Posted On Sep 16 2016 by

#spi pharma # SPI Pharma How do SPI Pharma fit into ABF Ingredients? SPI Pharma are a pharmaceutical company within ABF Ingredients, with headquarters in the USA and sites in the USA, France and India. SPI Pharma provides innovative solutions global pharmaceutical and nutritional customers need to succeed. SPI Pharma help customers solve even the most challenging formulation problems – efficiently, cost-effectively, and with a focus on service. SPI Pharma is headquartered in Wilmington Delaware, USA and has manufacturing locations in New Castle Delaware, Lewis Delaware, Grand Haven Michigan, and Septemes Les Vallons, France. In addition, SPI Pharma have a …


OxyContin s Deception Costs Firm $634M – CBS News

Posted On Sep 16 2016 by

#perdue pharma # OxyContin’s Deception Costs Firm $634M Two days after agreeing to pay states nearly $20 million for falsely marketing OxyContin, the drug’s maker, Perdue Pharma, and three current and former executives plead guilty to federal charges. The Stamford, Conn.-based maker of the powerful painkiller, and three of its current and former executives, pleaded guilty Thursday to misleading the public about OxyContin’s risk of addiction, a federal prosecutor and the company said. Purdue Pharma L.P. its president, top lawyer and former chief medical officer will pay $634.5 million in fines for claiming the drug was less addictive and less …


Sun Pharma to acquire US dermatology company DUSA Pharma

Posted On Sep 16 2016 by

#dusa pharma # Sun Pharma to acquire US dermatology company DUSA Pharma (Under the terms of the agreement, ) AHMEDABAD: Mumbai-based Sun Pharmaceutical Industries Ltd is set to acquire US-based DUSA Pharmaceuticals, Inc, a dermatology company focused on developing and marketing its Levulan (aminolevulinic acid HCl) photodynamic therapy platform. The two companies entered into a definitive agreement. Under the terms of the agreement, a 100% subsidiary of Sun Pharmaceutical Industries Ltd will commence a tender offer for all of the outstanding common stock of DUSA at a price of $8.00 per share in cash, a 38% premium to the closing …


DUSA – News and Analysis – DUSA Pharmaceuticals, Inc

Posted On Sep 16 2016 by

#dusa pharma # DUSA is a vertically integrated dermatology company that is developing and marketing Levulan PDT and other products for common skin conditions. We operate in two segments, Photodynamic Therapy, or PDT, Drug and Device Products and Non-Photodynamic Therapy, or Non-PDT, Drug Products. Our Levulan® Kerastick® and BLU-U® products comprise our PDT segment, while Nicomide®, ClindaReach® and the other products acquired in the acquisition of Sirius comprise our Non-PDT segment. Our currently marketed products include among others Levulan® Kerastick® 20% Topical Solution with photodynamic therapy, the BLU-U® brand light source, and certain products acquired in the March 10, 2006 …


Isis Pharma changes name to Ionis Pharma

Posted On Sep 16 2016 by

#isis pharma # From Isis Pharma to Ionis Isis Pharmaceuticals has changed its name to Ionis Pharmaceuticals, the Carlsbad biotech company announced Friday. With the new name — free of any similarities to the widely used acronym for the Islamic State terrorist group, comes a new stock ticker — IONS. That ticker goes into effect when trading opens on Dec. 22. The company is also getting a new website: www.ionispharma.com. But it wasn’t just the unsavory association that caused Isis to become Ionis, (pronounced “eye-OH-nis”) said Stanley T. Crooke, the company’s chairman and chief executive. It was the potential problems …


Biopharma

Posted On Sep 16 2016 by

#biopharma # Your project, our care Biopharma: production of ß-lactam antibiotics Orofino Sites Orofino Business Biopharma is a specialized manufacturer of Beta-Lactam antibiotics. The company was founded in 1989 by The Orofino Group and began the construction of the new Biopharma manufacturing site located at Santa Palomba in Rome, Italy. By 1995 it commenced commercial operations with the authorization from the regulatory authorities. As a result of a continual investment policy, the site has been kept up-to-date with the latest technologies and is now one of the most advanced in Europe. These technological capabilities, together with the high level of …


Jobs in pharmaceutical companies

Posted On Sep 16 2016 by

#jobs in pharmaceutical companies # Careers Pfizer Australia offers outstanding career opportunities within an organisation established as a premier employer of choice. Pfizer Australia is recognised for its excellence across all aspects of the healthcare business. Be it sales and marketing, research and development or manufacturing, our professionals are engaged in an environment where their talents, skills and drive for achievement are constantly in demand. Our track record of outstanding success has been fuelled by the dedication and dynamic nature of our people. Pfizer Australia is committed to the hiring, advancement and fair treatment of individuals without discrimination based on …